MIMO Biosciences: One year driving preclinical research against multiple myeloma
MIMO Biosciences, member of Navarra Health Cluster, celebrated its first year of activity in February — a journey already marked by key milestones, including its first capital increase at the end of 2024. Ricardo Pérez, CEO of MIMO Biosciences, introduces the company’s work focused on preclinical-stage drug research for various types of haematological cancers, such […]
Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off
Navarra Health Cluster and its member entity Asphalion launched a new training cycle titled “Regulatory Challenges in Pharmaceutical and Healthcare Innovation” on Tuesday 1 April, with a first session focused on the regulatory hurdles involved in innovation for medical devices, covering procedures in both Europe and the United States. The session, led by Talyta Carteano, […]
Navarra Health Cluster reaches 11% of the regional GDP and grows by 20% in member companies.
The entity’s General Assembly, held this Friday, revealed that the number of member organizations in the last fiscal year was 54. Their combined turnover exceeded €2.65 billion, they employed 18,600 people, and jointly invested more than €120 million in R&D. The cluster, for its part, offered them tailored services such as training workshops and new […]
FITECU 2025: keys to the future of the care sector
The presence of Navarra Health Cluster at the FITECU 2025 fair has been an enriching experience full of learning. Our main objective has been to attend in order to learn about the latest technological advances in the socio-health field. During the fair, we had the opportunity to explore innovations that can improve healthcare, such as […]
Nanogrow Biotech, the startup specialising in the development of dermatological treatments based on nanoantibodies
What are nanoantibodies and how can they be used to develop treatments for skin diseases? Nicolás Galmarini, CEO and co-founder of Nanogrow, an entity associated with Navarra Health Cluster, presents us with the characteristics of this technology and the path of his biotech start-up specialising in the development of nanoantibodies for the human and animal […]
Adacen: 3 decades of commitment, innovation and comprehensive care for people affected by brain damage
On the occasion of World Stroke Day, the Brain Damage Association of Navarra (Adacen), a member of Navarra Health Cluster, brought together companies and knowledge centres on October 29 at its centre with the aim of addressing Technologies for the rehabilitation of brain damage and promoting technology transfer in our sector. This day was the […]